|
AU2004253967B2
(en)
|
2003-07-03 |
2010-02-18 |
Cytovia, Inc. |
4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
|
|
US8309562B2
(en)
|
2003-07-03 |
2012-11-13 |
Myrexis, Inc. |
Compounds and therapeutical use thereof
|
|
JP2007518823A
(ja)
|
2004-01-23 |
2007-07-12 |
アムゲン インコーポレイテッド |
キノリン、キナゾリン、ピリジン、及びピリミジン化合物と炎症、血管新生、及び癌に対する治療におけるそれら化合物の用途
|
|
GEP20084439B
(en)
|
2004-01-23 |
2008-07-25 |
Amgen Inc |
Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof
|
|
PL1756084T3
(pl)
*
|
2004-06-04 |
2009-06-30 |
Arena Pharm Inc |
Podstawione pochodne arylowe i heteroarylowe jako modulatory metabolizmu oraz profilaktyka i leczenie zaburzeń z metabolizmem związanych
|
|
EP1802623A1
(en)
*
|
2004-10-12 |
2007-07-04 |
Novo Nordisk A/S |
11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds
|
|
JP2008521900A
(ja)
|
2004-11-30 |
2008-06-26 |
アムジエン・インコーポレーテツド |
キノリン及びキナゾリン類似体並びにがん治療のための医薬としてのその使用
|
|
GT200500375A
(es)
*
|
2004-12-20 |
2006-11-28 |
|
Derivados de piperidina y su uso como agentes antiinflamatorios
|
|
US8258145B2
(en)
|
2005-01-03 |
2012-09-04 |
Myrexis, Inc. |
Method of treating brain cancer
|
|
JO2787B1
(en)
|
2005-04-27 |
2014-03-15 |
امجين إنك, |
Alternative amide derivatives and methods of use
|
|
US7709516B2
(en)
*
|
2005-06-17 |
2010-05-04 |
Endorecherche, Inc. |
Helix 12 directed non-steroidal antiandrogens
|
|
KR20080069189A
(ko)
*
|
2005-11-01 |
2008-07-25 |
트랜스테크 파르마, 인크. |
치환된 아미드의 약학적 사용
|
|
EA200801243A1
(ru)
*
|
2005-11-01 |
2008-10-30 |
Транстек Фарма |
Фармацевтическое применение замещенных амидов
|
|
AU2006332694A1
(en)
*
|
2005-12-30 |
2007-07-12 |
Alantos Pharmaceuticals, Holding, Inc. |
Substituted bis-amide metalloprotease inhibitors
|
|
TW200804347A
(en)
*
|
2006-01-10 |
2008-01-16 |
Janssen Pharmaceutica Nv |
Urotensin II receptor antagonists
|
|
JP2009530346A
(ja)
*
|
2006-03-21 |
2009-08-27 |
ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー |
メタボリックシンドロームの治療用のアダマンタン誘導体
|
|
KR20090014347A
(ko)
|
2006-04-07 |
2009-02-10 |
하이 포인트 파마슈티칼스, 엘엘씨 |
11β-히드록시스테로이드 탈수소효소 타입 1 활성 화합물
|
|
EP2038255A2
(en)
*
|
2006-06-16 |
2009-03-25 |
High Point Pharmaceuticals, LLC |
Pharmaceutical use of substituted piperidine carboxamides
|
|
EP1878721A1
(en)
*
|
2006-07-13 |
2008-01-16 |
Novo Nordisk A/S |
4-Piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
|
WO2008006702A1
(en)
*
|
2006-07-13 |
2008-01-17 |
High Point Pharmaceuticals, Llc. |
11beta-hydroxysteroid dehydrogenase type 1 active compounds
|
|
CL2007002097A1
(es)
*
|
2006-07-20 |
2008-01-18 |
Smithkline Beecham Corp |
Compuestos derivados de pirrolidina o morfolina antagonistas de urotensina ii; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar insuficiencia cardiaca congestiva, insuficiencia cardiaca isquemica, angina, isquemia del miocardio, vejiga hiperactiva, asma y/o copd, entre otras.
|
|
WO2008016534A1
(en)
|
2006-07-31 |
2008-02-07 |
Janssen Pharmaceutica, N.V. |
Urotensin ii receptor antagonists
|
|
FR2904827B1
(fr)
|
2006-08-11 |
2008-09-19 |
Sanofi Aventis Sa |
Derives de 5,6-bisaryl-2-pyridine-carboxamide, leur preparation et leur application en therapeutique comme antiganistes des recepteurs a l'urotensine ii
|
|
WO2008059370A2
(en)
|
2006-11-17 |
2008-05-22 |
Pfizer Japan Inc. |
Substituted bicyclocarboxyamide compounds
|
|
WO2008101885A1
(en)
*
|
2007-02-23 |
2008-08-28 |
High Point Pharmaceuticals, Llc |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
EP2129652A2
(en)
*
|
2007-02-23 |
2009-12-09 |
High Point Pharmaceuticals, LLC |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
EP2150526B1
(en)
|
2007-02-23 |
2017-09-20 |
vTv Therapeutics LLC |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
EP2125704A1
(en)
*
|
2007-02-23 |
2009-12-02 |
High Point Pharmaceuticals, LLC |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
WO2008110196A1
(en)
*
|
2007-03-09 |
2008-09-18 |
High Point Pharmaceuticals, Llc |
Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors
|
|
US20100056600A1
(en)
*
|
2007-03-28 |
2010-03-04 |
Soren Ebdrup |
11beta-hsd1 active compounds
|
|
CN101677562A
(zh)
*
|
2007-04-11 |
2010-03-24 |
高点制药有限责任公司 |
新化合物
|
|
ES2393230T3
(es)
*
|
2007-04-24 |
2012-12-19 |
High Point Pharmaceuticals, Llc |
Uso farmacéutico de amidas sustituidas
|
|
PA8782701A1
(es)
|
2007-06-07 |
2009-01-23 |
Janssen Pharmaceutica Nv |
Antagonistas del receptor de urotensina ii
|
|
US20100190829A1
(en)
*
|
2007-06-20 |
2010-07-29 |
Vitae Pharmaceuticals Inc |
Renin inhibitors
|
|
CA2703257C
(en)
*
|
2007-10-29 |
2013-02-19 |
Amgen Inc. |
Benzomorpholine derivatives and methods of use
|
|
WO2009063364A2
(en)
*
|
2007-11-13 |
2009-05-22 |
Encysive Pharmaceuticals Inc. |
Modulators of urotensin receptor and methods of use thereof
|
|
FR2927330B1
(fr)
|
2008-02-07 |
2010-02-19 |
Sanofi Aventis |
Derives de 5,6-bisaryl-2-pyridine-carboxamide, leur preparation et leur application en therapeutique comme antagonistes des recepteurs a l'urotensine ii
|
|
UA103319C2
(en)
|
2008-05-06 |
2013-10-10 |
Глаксосмитклайн Ллк |
Thiazole- and oxazole-benzene sulfonamide compounds
|
|
ATE546448T1
(de)
|
2008-08-02 |
2012-03-15 |
Janssen Pharmaceutica Nv |
Urotensin-ii-rezeptorantagonisten
|
|
EP2632461A4
(en)
*
|
2010-10-29 |
2014-04-02 |
Merck Sharp & Dohme |
Isoindolinone PDE10 INHIBITORS
|
|
CN102060811A
(zh)
*
|
2011-01-19 |
2011-05-18 |
山西大学 |
单磺酰哌嗪的合成方法
|
|
DK2935222T3
(en)
|
2012-12-21 |
2019-01-07 |
Epizyme Inc |
PRMT5 INHIBITORS AND APPLICATIONS THEREOF
|
|
US9745291B2
(en)
|
2012-12-21 |
2017-08-29 |
Epizyme, Inc. |
PRMT5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
|
|
CA2894126A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
|
CA2899363A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
|
JP2016511744A
(ja)
*
|
2012-12-21 |
2016-04-21 |
エピザイム，インコーポレイティド |
Ｐｒｍｔ５を阻害する方法
|
|
JP2016505597A
(ja)
|
2012-12-21 |
2016-02-25 |
エピザイム，インコーポレイティド |
Ｐｒｍｔ５阻害剤およびその使用
|
|
CA2903813C
(en)
|
2013-03-15 |
2023-08-29 |
Epizyme, Inc. |
Carm1 inhibitors and uses thereof
|
|
WO2014144455A1
(en)
|
2013-03-15 |
2014-09-18 |
Epizyme, Inc. |
1 -phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof
|
|
WO2015054662A1
(en)
|
2013-10-10 |
2015-04-16 |
Eastern Virginia Medical School |
4-((2-hydroxy-3-methoxybenzyl)amino) benzenesulfonamide derivatives as 12-lipoxygenase inhibitors
|
|
JP6272604B2
(ja)
*
|
2013-12-27 |
2018-01-31 |
日本サプリメント株式会社 |
糖取り込み促進剤
|
|
CA2935683A1
(en)
*
|
2013-12-30 |
2015-07-09 |
Lifesci Pharmaceuticals, Inc. |
Therapeutic inhibitory compounds
|
|
WO2016022605A1
(en)
|
2014-08-04 |
2016-02-11 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
|
TWI735416B
(zh)
|
2014-10-06 |
2021-08-11 |
美商維泰克斯製藥公司 |
囊腫纖維化症跨膜傳導調節蛋白之調節劑
|
|
US10752588B2
(en)
|
2014-12-19 |
2020-08-25 |
The Broad Institute, Inc. |
Dopamine D2 receptor ligands
|
|
WO2016100940A1
(en)
|
2014-12-19 |
2016-06-23 |
The Broad Institute, Inc. |
Dopamine d2 receptor ligands
|
|
ES2946970T3
(es)
|
2016-03-31 |
2023-07-28 |
Vertex Pharma |
Regulador de conductancia transmembrana de moduladores de fibrosis quística
|
|
EP3241874B1
(en)
|
2016-05-04 |
2019-08-14 |
Agfa Nv |
Acylphosphine oxide photoinitiators
|
|
SI3519401T1
(sl)
|
2016-09-30 |
2022-01-31 |
Vertex Pharmaceuticals Incorporated |
Modulator regulatorja transmembranske prevodnosti pri cistični fibrozi, farmacevtski sestavki, postopki zdravljenja in proces za izdelavo modulatorja
|
|
CN110267948B
(zh)
|
2016-12-09 |
2023-12-08 |
弗特克斯药品有限公司 |
囊性纤维化跨膜传导调控剂的调节剂、药物组合物、治疗方法和制备所述调节剂的方法
|
|
WO2018122746A1
(en)
|
2016-12-28 |
2018-07-05 |
Minoryx Therapeutics S.L. |
Isoquinoline compounds, methods for their preparation, and therapeutic uses thereof in conditions associated with the alteration of the activity of beta galactosidase
|
|
JP7017797B2
(ja)
*
|
2017-02-24 |
2022-02-09 |
深▲チェン▼市霊蘭生物医薬科技有限公司 |
新規なドーパミンｄ３受容体選択的リガンド及びびその調製方法並びに医薬使用
|
|
AU2018279646B2
(en)
|
2017-06-08 |
2023-04-06 |
Vertex Pharmaceuticals Incorporated |
Methods of treatment for cystic fibrosis
|
|
MA49631A
(fr)
|
2017-07-17 |
2020-05-27 |
Vertex Pharma |
Méthodes de traitement de la fibrose kystique
|
|
TWI799435B
(zh)
|
2017-08-02 |
2023-04-21 |
美商維泰克斯製藥公司 |
製備化合物之製程
|
|
US10654829B2
(en)
|
2017-10-19 |
2020-05-19 |
Vertex Pharmaceuticals Incorporated |
Crystalline forms and compositions of CFTR modulators
|
|
KR102716244B1
(ko)
|
2017-12-08 |
2024-10-14 |
버텍스 파마슈티칼스 인코포레이티드 |
낭포성 섬유증 막횡단 전도 조절자의 조정제의 제조 방법
|
|
TWI810243B
(zh)
|
2018-02-05 |
2023-08-01 |
美商維泰克斯製藥公司 |
用於治療囊腫纖化症之醫藥組合物
|
|
EP3774825A1
(en)
|
2018-04-13 |
2021-02-17 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
|
|
CN111170897A
(zh)
*
|
2019-12-18 |
2020-05-19 |
荆门市丽康源纺织科技有限公司 |
一种间位酯的制备方法及间位酯
|
|
CN110938021A
(zh)
*
|
2019-12-18 |
2020-03-31 |
荆门市丽康源纺织科技有限公司 |
一种染料中间体3-(β-羟乙基砜基)苯胺的制备方法
|
|
MX2023003476A
(es)
*
|
2020-09-25 |
2023-06-22 |
Escient Pharmaceuticals Inc |
Moduladores del receptor x2 de proteína g relacionado con mas y productos y métodos relacionados.
|
|
CN114890946B
(zh)
*
|
2022-05-20 |
2023-10-27 |
沈阳药科大学 |
含有吗啉丙基的[(喹啉-4-基)氨基]苯甲酰胺类化合物及其制备与应用
|